Publication Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion. Majumder V, Saha B, Hajra S K, et al. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 2000; 68 (3) : 283-90. Download PDF
Publication Concomitant kala-azar, malaria, and progressive unstable indeterminate leprosy in an 8-year-old child. Saha K, Chattopadhya D, Kulpati D D. Journal of tropical pediatrics. 1998; 44 (4) : 247-8.
Publication Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons form Convit's experiment on bacteria-clearing capacity of lepromin-induced granuloma. Chaudhuri S, Hajra S K, Mukherjee A, et al. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1998; 66 (2) : 182-9. Download PDF
Publication Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta. Chaudhury S, Hajra S K, Mukerjee A, et al. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1997; 65 (1) : 56-62. Download PDF
Publication Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial). Majumder V, Mukerjee A, Hajra S K, et al. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1996; 64 (1) : 26-36. Download PDF
Publication Biometals in skin and sera of leprosy patients and their correlation to trace element contents of M. leprae and histological types of the disease; a comparative study with cutaneous tuberculosis. Jain A, Mukherjee A, Chattopadhya D, et al. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1995; 63 (2) : 249-58. Download PDF
Publication Enhanced response of serum IgG class of anti-PGL-I antibodies in leprosy patients during onset and following clinical remission of type 1 and type 2 reactions. Saha K, Chattopadhya D, Kashyup A, et al. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1995; 63 (1) : 105-9. Download PDF
Publication An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis. Chaudhury S, Hazra S K, Saha B, et al. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1994; 62 (3) : 389-94. Download PDF
Publication Tumor necrosis factor: status in reactions in leprosy before and after treatment. Bhattacharya S N, Chattopadhaya D, Saha K. International journal of dermatology. 1993; 32 (6) : 436-9.
Publication In vivo effects of anti-leprosy drugs on the rat peritoneal macrophages and lymphocyte subpopulations. Sahu A, Saha K, Mukherjee A, et al. International journal of immunopharmacology. 1992; 14 (4) : 721-30.
Publication Nutritional status of children of urban leprosy patients staying at preventoria based on biochemical parameters. Chattopadhya D, Saha K, Chakrabarty A K, et al. European journal of clinical nutrition. 1992; 46 (12) : 885-95.
Publication Anti-leprosy drugs inhibit the complement-mediated solubilization of pre-formed immune complexes in vitro. Kashyap A, Sehgal V N, Sahu A, et al. International journal of immunopharmacology. 1992; 14 (2) : 269-73.
Publication Reconstruction of anti-leprosy drug depleted complement haemolytic activity by addition of zymosan-treated sera (a source of C142) and CratEDTA (a source of C3-C9). Kashyap A, Saha K, Sehgal V N. International journal of immunopharmacology. 1992; 14 (8) : 1409-14.
Publication Effect of anti-leprosy drugs on superoxide anion production by rat peritoneal macrophage with special reference to light exposed clofazimine. Sahu A, Saha K, Banerjee N R, et al. International journal of immunopharmacology. 1991; 13 (4) : 419-28.
Publication Sexually transmitted diseases in leprosy patients in north and northeastern India. A futile search for human immunodeficiency virus antibody. Saha K, Chattopadhya D, Dash K, et al. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1990; 58 (4) : 660-5. Download PDF
Publication A study on nutrition, growth and development of a high-risk group of children of urban leprosy patients. Saha K, Rao K N, Chattopadhya D, et al. European journal of clinical nutrition. 1990; 44 (6) : 471-9.
Publication Serum ferritin in lepra reactions. Saha K, Rao K N, Kashyap A, et al. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1989; 57 (4) : 867-70. Download PDF
Publication Toxoplasma gondii antibody in patients of lepromatous leprosy. Rao K N, Saha K, Bhatia V N, et al. Japanese journal of medical science & biology. 1989; 42 (5-6) : 163-8.
Publication Undernutrition in lepromatous leprosy. V. Severe nutritional deficit in lepromatous patients co-infected with pulmonary tuberculosis. Saha K, Rao K N. European journal of clinical nutrition. 1989; 43 (2) : 117-28.
Publication Interaction of anti-leprosy drugs with the rat serum complement system. Sahu A, Saha K, Kashyap A, et al. Immunopharmacology. 1988; 15 (3) : 143-50.